Literature DB >> 16257511

Transformation of a prefabricated hydroxyapatite/osteogenic protein-1 implant into a vascularised pedicled bone flap in the human chest.

M Heliotis1, K M Lavery, U Ripamonti, E Tsiridis, L di Silvio.   

Abstract

We describe the intramuscular transformation of a hydroxyapatite/osteogenic protein-1 (HA/OP-1) composite implant, into a vascularised pedicled bone flap useful for reconstruction of a hemi-mandible. Extraskeletal induction of a bone flap for transplantation was achieved without the addition of harvested bone, bone marrow, or stem cells. Five months after apparent clinical success, an MRSA infection of the graft led to its failure. The background to ectopically induced bone flaps is introduced, with our experience in a human case presented. The results from this emerging biotechnology are discussed in the light of limited human clinical experience.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16257511     DOI: 10.1016/j.ijom.2005.07.013

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  25 in total

Review 1.  Brief review of models of ectopic bone formation.

Authors:  Michelle A Scott; Benjamin Levi; Asal Askarinam; Alan Nguyen; Todd Rackohn; Kang Ting; Chia Soo; Aaron W James
Journal:  Stem Cells Dev       Date:  2012-01-04       Impact factor: 3.272

Review 2.  Mandibular Reconstruction: Overview.

Authors:  Batchu Pavan Kumar; V Venkatesh; K A Jeevan Kumar; B Yashwanth Yadav; S Ram Mohan
Journal:  J Maxillofac Oral Surg       Date:  2015-04-19

3.  Bone Morphogenetic Protein-2 Adsorption onto Poly-ɛ-caprolactone Better Preserves Bioactivity In Vitro and Produces More Bone In Vivo than Conjugation Under Clinically Relevant Loading Scenarios.

Authors:  Janki J Patel; Colleen L Flanagan; Scott J Hollister
Journal:  Tissue Eng Part C Methods       Date:  2015-02-04       Impact factor: 3.056

4.  Large Animal Models of an In Vivo Bioreactor for Engineering Vascularized Bone.

Authors:  Banu Akar; Alexander M Tatara; Alok Sutradhar; Hui-Yi Hsiao; Michael Miller; Ming-Huei Cheng; Antonios G Mikos; Eric M Brey
Journal:  Tissue Eng Part B Rev       Date:  2018-04-12       Impact factor: 6.389

Review 5.  In vivo bioreactors for mandibular reconstruction.

Authors:  A M Tatara; M E Wong; A G Mikos
Journal:  J Dent Res       Date:  2014-08-19       Impact factor: 6.116

Review 6.  Soluble and insoluble signals and the induction of bone formation: molecular therapeutics recapitulating development.

Authors:  Ugo Ripamonti; C Ferretti; M Heliotis
Journal:  J Anat       Date:  2006-10       Impact factor: 2.610

7.  Dual Delivery of EPO and BMP2 from a Novel Modular Poly-ɛ-Caprolactone Construct to Increase the Bone Formation in Prefabricated Bone Flaps.

Authors:  Janki Jayesh Patel; Jane E Modes; Colleen L Flanagan; Paul H Krebsbach; Sean P Edwards; Scott J Hollister
Journal:  Tissue Eng Part C Methods       Date:  2015-07-22       Impact factor: 3.056

8.  Soluble and insoluble signals sculpt osteogenesis in angiogenesis.

Authors:  Ugo Ripamonti
Journal:  World J Biol Chem       Date:  2010-05-26

9.  Autologously generated tissue-engineered bone flaps for reconstruction of large mandibular defects in an ovine model.

Authors:  Alexander M Tatara; James D Kretlow; Patrick P Spicer; Steven Lu; Johnny Lam; Wei Liu; Yilin Cao; Guangpeng Liu; John D Jackson; James J Yoo; Anthony Atala; Jeroen J J P van den Beucken; John A Jansen; F Kurtis Kasper; Tang Ho; Nagi Demian; Michael John Miller; Mark E Wong; Antonios G Mikos
Journal:  Tissue Eng Part A       Date:  2015-03-03       Impact factor: 3.845

10.  Investigation of a Prevascularized Bone Graft for Large Defects in the Ovine Tibia.

Authors:  Yunzhi Peter Yang; Benjamin C Gadomski; Arnaud Bruyas; Jeremiah Easley; Kevin M Labus; Brad Nelson; Ross H Palmer; Holly Stewart; Kirk McGilvray; Christian M Puttlitz; Dan Regan; Alexander Stahl; Elaine Lui; Jiannan Li; Seyedsina Moeinzadeh; Sungwoo Kim; William Maloney; Michael J Gardner
Journal:  Tissue Eng Part A       Date:  2021-06-11       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.